Nila Rafiq

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

Nila Rafiq, Chunhong Bai, Yun Fang et al. · Clinical Gastroenterology and Hepatology · 2008 · 734 citations

Medicine, Internal Medicine, Pathology +12

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

Zobair M. Younossi, Maria Stepanova, Nila Rafiq et al. · Hepatology · 2011 · 636 citations

Medicine, Pathology, Autopsy Pathology +16

Epidemiology of chronic liver diseases in the USA in the past three decades

Zobair M. Younossi, Maria Stepanova, Youssef Younossi et al. · Gut · 2019 · 559 citations

Medicine, Nutrition, Epidemiologic Methods +9

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12